Skip to main content

Find Clinical Trials

Home
Conditions
Hyperphosphatemia

Clinical trial condition

Hyperphosphatemia

Explore clinical trials studying Hyperphosphatemia. Study availability and eligibility vary by location and protocol.

122 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hyperphosphatemia trial results

Completed

A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

NCT00505037

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Chugoku, Japan

Chūbu, Japan

Kansai, Japan

Kanto, Japan

View Trial Details

Completed

Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia

NCT01057108

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +14 more
Locations: Denver Nephrologists, PC Denver, Colorado, United States

View Trial Details

Completed

Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients

NCT00317694

Conditions: Chronic Disease, Chronic Kidney Failure, Disease Attributes, +15 more
Locations: 1614 West 42nd Street Pine Bluff, Arkansas, United States

US Renal Care Stuttgart, Arkansas, United States

Davita Dialysis Center Charlotte, North Carolina, United States

Southeast Renal Associates Charlotte, North Carolina, United States

View all 15 locations

View Trial Details

Completed

Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With Hyperphosphataemia

NCT00436683

Conditions: Chronic Disease, Chronic Kidney Failure, Disease Attributes, +15 more
Locations: Department of Renal Medicine, Derby City General Hospital, Uttoxeter Road Derby, Derbyshire, United Kingdom

Queens Dialysis Unit, Rom Valley Way Romford, Essex, United Kingdom

Renal Unit, Queen Elizabeth Hospital, Edgbaston Birmingham, United Kingdom

Ash Haemodialysis Unit, Hospital of St Cross, University Hospital of Coventry & Warwickshire NHS Trust, Clifford Bridge Road Coventry, United Kingdom

View all 15 locations

View Trial Details

Completed

Phosphorus Improvement Pilot Study

NCT00583570

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Not specified

View Trial Details

Completed

Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers

NCT00742820

Conditions: Hyperphosphatemia, Metabolic Diseases, Nutritional and Metabolic Diseases, +1 more
Locations: Community Research Cincinnati, Ohio, United States

View Trial Details

Completed

The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients

NCT00316472

Conditions: Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +29 more
Locations: Washington University Medical Center St Louis, Missouri, United States

View Trial Details

Completed

EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)

NCT00211978

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hyperphosphatemia, +9 more
Locations: University of Texas Health Sciences Center San Antonio, Texas, United States

View Trial Details

Completed

CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients

NCT00211939

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Calcinosis, +18 more
Locations: University of Texas Health Sciences Center San Antonio, Texas, United States

View Trial Details

Completed

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

NCT00508885

Conditions: Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +29 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details